U.S. Markets open in 8 hrs 23 mins

Better Marijuana Stock: Canopy Growth vs. Constellation Brands

Keith Speights, The Motley Fool

Constellation Brands (NYSE: STZ) first rocked Canopy Growth's (NYSE: CGC) world in 2017 by buying a 9.9% stake in the Canadian cannabis producer. A year later, Constellation made an even bigger impact with a $4 billion investment in Canopy. The big alcoholic beverage maker now has enough sway over Canopy Growth that it was able to boot founder and former CEO Bruce Linton out the door earlier this month.

But while Constellation Brands and Canopy Growth are joined at the hip, the reasons to buy the stocks aren't exactly the same. Which is the better pick for long-term investors? 

Giant marijuana leaf in a shopping cart

Image source: Getty Images.

The case for Canopy Growth

There's really only one big reason why Canopy Growth could be the better choice over its partner: A much greater growth opportunity. As a pure-play marijuana stock, Canopy Growth is poised to benefit more over the long run if the global cannabis market expands like many think it will.

Some investors might be tempted to focus heavily on Canopy's lackluster performance in its last quarterly update. That's a mistake. Canopy Growth's revenue wasn't as high as hoped primarily because of supply constraints. But low capacity is only a temporary problem.

Canopy Growth ranks as the leader in the Canadian adult-use recreational pot market and will likely remain at the top. The company should be in a great position as the second phase of this market opens later this year with cannabis derivatives including beverages, edibles, and vapes becoming available.

International medical cannabis markets present another huge opportunity for Canopy Growth. Although the company trails Aurora Cannabis in international sales, it's still a major player in Europe, South America, and Australia. As these markets mature, Canopy Growth's revenue will increase dramatically.

Then there's the U.S. Canopy Growth is arguably in the best position of any Canadian cannabis producer to reach the huge U.S. market. It's building a large-scale hemp production facility in New York state with hemp CBD products expected to hit the market by the end of this year. Canopy's deal to buy the right to acquire U.S.-based cannabis operator Acreage Holdings as soon as federal laws permit also puts the company in the catbird's seat to enter the U.S. marijuana market.

The main drawback for Canopy Growth is that it remains unprofitable. However, it seems likely that the company's next CEO will focus on mapping out a clear path to profitability. And Canopy is already on track to generate positive earnings before interest, taxes, depreciation, and amortization (EBITDA) with its Canadian operations next year.

The case for Constellation Brands

Why buy Constellation Brands stock? First, it has a strong core business in alcoholic beverages. Second, it also should have tremendous growth prospects in the global cannabis market thanks to its 38% ownership of Canopy Growth.

Constellation continues to dominate the premium beer market in the U.S. with its Corona and Modelo brands leading the way. The company's products generated 40% of the growth in the U.S. high-end beer category last year. Even more impressive, Constellation's beers basically accounted for all of the growth in the import segment of the market.

Some might point out that Constellation hasn't fared so well with its wine and spirits products. However, the company is selling over 30 of its wine and spirit brands to E. & J. Gallo. This deal should enable Constellation to focus its attention on higher-profit brands. It will also bring in a cool $1.7 billion in cash.

Because of its stake in Canopy Growth, Constellation should reap the rewards from rapid growth in cannabis markets across the world. But won't Canopy growth even more? Yes. However, Constellation owns warrants that allow it to gain a majority interest in its partner. You can bet that it will exercise those warrants if the global cannabis market explodes.

While Canopy Growth isn't profitable yet, Constellation ranks as one of the top two most profitable marijuana stocks on the market. Don't let the company's loss in Q1 fool you. Constellation Brands would have reported a nice profit were it not for the negative impact of Canopy Growth's results.

Constellation's strong financial position enables it to pay an attractive dividend as well. The dividend currently yields 1.5%. With a payout ratio of less than 24%, Constellation should be in a good position to increase its dividends in the future. 

Better marijuana stock

I'm not nearly as down on Canopy Growth as some investors seem to be right now. My view is that the company's long-term prospects remain very good. But if I had to choose only of these stocks to buy, it would be Constellation Brands.

My thinking is that if the cannabis opportunity proves to be really attractive, it's likely that Constellation will fully acquire Canopy Growth. And if the cannabis market doesn't grow as quickly as hoped, Constellation's alcoholic beverages business gives it a hedge that Canopy doesn't have. 

Constellation Brands has a long and successful track record in rewarding shareholders. The company's management team knows what it's doing in the U.S. alcoholic beverages market. And with its stake in Canopy Growth, Constellation has a cannabis lottery ticket that could pay off in a huge way. 

More From The Motley Fool

Keith Speights has no position in any of the stocks mentioned. The Motley Fool recommends Constellation Brands. The Motley Fool has a disclosure policy.

  • Why You Should Leave Innophos Holdings, Inc. (NASDAQ:IPHS)'s Upcoming Dividend On The Shelf
    Business
    Simply Wall St.

    Why You Should Leave Innophos Holdings, Inc. (NASDAQ:IPHS)'s Upcoming Dividend On The Shelf

    Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see Innophos Holdings, Inc. (NASDAQ:IPHS) is about to trade ex-dividend in the next 4 days. Innophos Holdings's next dividend payment will be US$0.48 per share, on the back of last year when the company paid a total of US$1.92 to shareholders. Based on the last year's worth of payments, Innophos Holdings has a trailing yield of 7.2% on the current stock price of $26.49.

  • Dow Jones Futures: Trump's China Trade News Aids Stock Market Rally; Analyzing Apple, These Top Stocks
    Business
    Investor's Business Daily

    Dow Jones Futures: Trump's China Trade News Aids Stock Market Rally; Analyzing Apple, These Top Stocks

    Dow Jones futures rose Sunday night, along with S&P 500 futures and Nasdaq futures, amid China trade war comments from President Donald Trump. A newly confirmed stock market rally came under pressure right away. The major averages suffered weekly losses in a wild week with conflicting China trade war news and a rare Treasury yield curve inversion.

  • Oil prices climb after Saudi oilfield attack, but recession worries drag
    World
    Reuters

    Oil prices climb after Saudi oilfield attack, but recession worries drag

    Crude oil prices rose on Monday following a weekend attack on a Saudi oil facility by Yemeni separatists and as traders looked for any signs that Sino-U.S. trade tensions could ease. "Oil is benefiting from an overall optimism that we won't see the doomsday trade war scenario and after a drone attack on oil and gas facilities in Saudi Arabia reminded markets geopolitical tensions in the Middle East are going nowhere anytime soon," said Edward Moya, senior market analyst at OANDA in New York. A drone attack by Yemen's Houthi group on an oilfield in eastern Saudi Arabia on Saturday caused a fire at a gas plant, adding to Middle East tensions, but state-run Saudi Aramco said oil production was not affected.

  • A gun law case before the US Supreme Court has Americans up in arms
    Finance
    Quartz

    A gun law case before the US Supreme Court has Americans up in arms

    The US Supreme Court will soon consider the right to bear arms, something it hasn't done for nearly a decade. The case in question has pitted New York City against the New York State Pistol and Rifle Association over a law on transporting guns. The twist here is that New York City, and its many legal allies, say the case is actually moot.

  • Mark Cuban explains how to make a 16% guaranteed return
    Business
    MarketWatch

    Mark Cuban explains how to make a 16% guaranteed return

    As Mark Cuban, the “Shark Tank” star, billionaire entrepreneur, and NBA franchise owner explains, just pay off your debts. The personal finance site NerdWallet put our revolving credit card balance at $420.22 billion in late 2018. The revolving number is just the credit card debt we carry from month to month.

  • Trump Administration Asks Supreme Court to Permit Employment Discrimination Against Transgender Workers
    Politics
    Meredith Videos

    Trump Administration Asks Supreme Court to Permit Employment Discrimination Against Transgender Workers

    The Trump administration's Department of Justice is asking the Supreme Court to set a legal precedent that would enable employers to fire employees because they are transgender.

  • These 16 money wasters are why so many Americans can’t save for retirement
    News
    MarketWatch

    These 16 money wasters are why so many Americans can’t save for retirement

    From the lofty perch of old age, and after a lifetime of thrift, I declare that I am qualified to comment on how not to waste money. We've all heard the reports: Most Americans live paycheck to paycheck, a large number can't come up with $400 for an emergency, and there's no money to save for retirement and other goals. Most of that data comes from surveys where people are, in effect, saying they don't have enough income.

  • 10 Marijuana Stocks Wall Street Thinks Will Double
    Business
    Motley Fool

    10 Marijuana Stocks Wall Street Thinks Will Double

    Here you'll see just how much these 10 marijuana stocks would need to increase to hit Wall Street's consensus price target. MedMen Enterprises: 196% upside You might be surprised to learn that among the dozens of well-known pot stocks to choose from, upscale dispensary operator MedMen Enterprises (OTC: MMNFF) is furthest from Wall Street's price target, which implies an almost tripling in value. MedMen certainly has a knack for normalizing the cannabis buying experience, is set to entrench itself in big markets like California and Florida, and will double its state-based reach when its acquisition of PharmaCann closes.

  • I built a nest egg of $1 million and I’m only 46 — so why do I still spend my waking hours worrying?
    Business
    MarketWatch

    I built a nest egg of $1 million and I’m only 46 — so why do I still spend my waking hours worrying?

    We have over $1 million in investments for ourselves, an additional $50,000 in investments for our two girls to be used for college. We have made investing mistakes, but we have learned from them. All told, we currently have over $1 million in investments for ourselves, an additional $50,000 in investments (529s and a Scottrade custodial account) for our two girls to be used for college, with our only debt being the final few years of our mortgage.

  • A cord-cutter’s guide to all the big new streaming services
    News
    Quartz

    A cord-cutter’s guide to all the big new streaming services

    We know that four major global media companies are planning to launch streaming services in the near future: WarnerMedia (owner of HBO and Warner Bros. Disney (owner of Marvel, Lucasfilm, and Pixar), Apple (owner of…phones), and NBCUniversal (owner of The Office and lots of other TV shows and movies). Their goal?

  • What a BAANG Stock Is -- and the Best Options for Your Portfolio
    Business
    Motley Fool

    What a BAANG Stock Is -- and the Best Options for Your Portfolio

    Roque is clearly suggesting investors look at the BAANG stocks, but not all gold stocks are created equal. Barrick, AngloGold, Agnico Eagle Mines, and Gold Fields are all precious metals miners. Their top and bottom lines are clearly tied to the ups and downs of gold and silver prices, but there's more to the picture than that.

  • Better Buy: GW Pharmaceuticals vs. Amarin
    Business
    Motley Fool

    Better Buy: GW Pharmaceuticals vs. Amarin

    Which biotech am I referring to: GW Pharmaceuticals (NASDAQ: GWPH) or Amarin (NASDAQ: AMRN)? Amarin has delivered much higher gains over the last 12 months. If you're GW Pharmaceuticals, the answer is E-P-I-D-I-O-L-E-X. The cannabidiol (CBD) drug Epidiolex is off to a fantastic start after launching in the U.S. late last year as a treatment for Dravet syndrome and Lennox-Gastaut syndrome (LGS), two rare forms of epilepsy.

  • 3 Dividend Stocks That Should Pay You the Rest of Your Life
    Business
    Motley Fool

    3 Dividend Stocks That Should Pay You the Rest of Your Life

    There's a balance in the dividend space between high yields and dividend sustainability. In the end, it's generally more important to find stocks that can keep paying -- and hopefully increasing -- their dividends than to stretch for high yields that are ephemeral because they are backed by dividends that are likely to get cut. If you want to add a few good dividend names to your portfolio, these three Motley Fool contributors think you'll want to look at biotech Gilead Sciences (NASDAQ: GILD), telecom giant Verizon (NYSE: VZ), and consumer products specialist Procter & Gamble (NYSE: PG).

  • Copy insiders and buy these stocks — because they see no recession looming
    Business
    MarketWatch

    Copy insiders and buy these stocks — because they see no recession looming

    I recently told subscribers of my stock letter Brush Up on Stocks to get more bullish on stocks because of robust insider buying in cyclical sectors like tech, banks, industrials, chemicals, airlines, autos, hotels, energy, mining, and brokerage and investment companies. Insiders would definitely not be doing this if — like Gundlach — they saw a recession on the way. Instead, they'd be on a buyer's strike, or at best they'd favor utilities or consumer non-discretionary companies.

  • I Lost $34,000 This Week: Here's What I'm Doing About It
    Business
    Motley Fool

    I Lost $34,000 This Week: Here's What I'm Doing About It

    That's because I have a fundamental understanding that stocks will almost certainly prove to be the best way to grow my wealth over the next two-plus decades, and the only way to attain those returns is to ride out volatility without letting fear take the reins and cause me to sell at the worst time: when my portfolio has lost value. To the contrary, I've taken advantage of these sell-offs and been a buyer over the past month. Moreover, I have measurable evidence that this strategy works.

  • Don't Be Tempted by Macy's Big Dividend Yield
    Business
    Motley Fool

    Don't Be Tempted by Macy's Big Dividend Yield

    Macy's reaffirmed its guidance for roughly flat sales growth for the full year but slashed its EPS guidance from $3.05-$3.25 to $2.85-$3.05 -- which would equal a 27% to 32% drop from 2018. Wall Street had expected a 27% decline. Macy's big post-earnings drop reduced its forward P/E to 6 and boosted its dividend yield to 8%.

  • Florida Vacation Home Invaded By Dozens of Vomiting Vultures
    U.S.
    Meredith Videos

    Florida Vacation Home Invaded By Dozens of Vomiting Vultures

    A New York couple's luxurious vacation house in Florida has been taken over by dozens of black vultures that are vomiting and defecating everywhere.

  • Kevin O’Leary: This easy math trick helps you crush retirement goals
    Business
    MarketWatch

    Kevin O’Leary: This easy math trick helps you crush retirement goals

    “Shark Tank” star Kevin O'Leary has some simple advice for anyone who finds investing scary: Just do it. Ten percent might not sound like a lot, but the reason O'Leary is right is the mathematical fact of compounding interest. If you save, say, $5,000 in one year, a typical stock market return in a diversified, low-cost index fund means that a year later you will have $5,365.

  • 3 High-Growth Stocks That Are Just Getting Started
    Business
    Motley Fool

    3 High-Growth Stocks That Are Just Getting Started

    Powering the rise of solar energy Maxx Chatsko (Enphase Energy): Sure, shares of Enphase Energy have soared 580% since the beginning of the year, but first-half 2019 operating results suggest there's plenty of room to run. The solar hardware provider reported 60% year-over-year revenue growth and a nearly $28 million increase in operating income in that span. The most recent quarterly results actually exceeded management's long-term targets for gross profits, operating expenses, and operating income, but CEO Badri Kothandaraman said he's going to wait a few more quarters before setting new operating targets.

  • San Francisco doesn't care about the stock market
    Business
    Yahoo Finance

    San Francisco doesn't care about the stock market

    It's not to say that people in San Francisco don't care about stocks or the economy. A banker who works closely with many tech companies told me, “They don't know about the stock market. With options making up a considerable chunk of a tech employee's compensation, it's no surprise employees so closely track a company stock price, but it can be a distraction.

  • 3 Dividend Stocks Ideal for Retirees
    Business
    Motley Fool

    3 Dividend Stocks Ideal for Retirees

    In an ideal world, retirement would be a period of relaxation and relatively stress-free living. Some individuals find retirement to be more expensive, stressful, or boring than they envisioned during their working years. One way to make retirement a little more enjoyable is to make your nest egg go further than you thought possible -- and one way to do that is by owning stable, blue-chip dividend stocks.

  • Why This Oil Stock Believes It Will Be a Big Winner Over the Long Term
    Business
    Motley Fool

    Why This Oil Stock Believes It Will Be a Big Winner Over the Long Term

    About to start up the fourth engine CEO John Hess stated on the call: Our portfolio, which is balanced between our growth engines in Guyana and the Bakken and our cash engines in the deepwater Gulf of Mexico and the Gulf of Thailand, is on track to generate industry-leading cash flow growth. With a portfolio breakeven that is expected to decrease to less than $40 per barrel Brent by 2025. A key driver of our strategy is our position in Guyana.

  • Here's Why We Think Sirius XM Holdings (NASDAQ:SIRI) Is Well Worth Watching
    Business
    Simply Wall St.

    Here's Why We Think Sirius XM Holdings (NASDAQ:SIRI) Is Well Worth Watching

    In contrast to all that, I prefer to spend time on companies like Sirius XM Holdings (NASDAQ:SIRI), which has not only revenues, but also profits. How Fast Is Sirius XM Holdings Growing? As one of my mentors once told me, share price follows earnings per share (EPS).

  • The new math of saving for retirement may boil down to this one, absurdly simple rule
    News
    MarketWatch

    The new math of saving for retirement may boil down to this one, absurdly simple rule

    There's research that can help — from institutions that don't have a conflict of interest because they don't invest or give advice. My favorite is the Employee Benefits Research Institute in Washington, D.C. EBRI, as it's called, gathered anonymous information on tens of millions of people and how they actually save. It won't tell people what to do, but from its research there's a pretty useful rule of thumb for young people: Count on your fingers and … Save 10% — now Between you and your employer, set aside at least 10% of your paycheck.

  • Apple CEO warns Trump about China tariffs, Samsung competition
    Business
    Reuters

    Apple CEO warns Trump about China tariffs, Samsung competition

    President Donald Trump said on Sunday that he had spoken with Apple Inc's Chief Executive Tim Cook about the impact of U.S. tariffs on Chinese imports as well as competition from South Korean company Samsung Electronics Co Ltd. Trump said Cook "made a good case" that tariffs could hurt Apple, given that Samsung's products would not be subject to those same tariffs. Tariffs on an additional $300 billion worth of Chinese goods, including consumer electronics, are scheduled to go into effect in two stages on Sept. and Dec. 15.